Centene (CNC) Wins Contract From Arizona's Medicaid Agency
https://www.zacks.com/stock/news/2193148/centene-cnc-wins-contract-from-arizona-s-medicaid-agency?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193148
Dec 04, 2023 - Centene's (CNC) Arizona subsidiary has been chosen by the AHCCCS to improve health outcomes for the state's ALTCS-E/PD members and further solidify statewide presence.
0
Roche (RHHBY) to Acquire Obesity Drug Maker Carmot for $2.7B
https://www.zacks.com/stock/news/2193099/roche-rhhby-to-acquire-obesity-drug-maker-carmot-for-2-7b?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193099
Dec 04, 2023 - Roche (RHHBY) aims to enter the promising and much-in-demand obesity drug market with the acquisition of Carmot Therapeutics, Inc. for $2.7 billion.
0
Everyone Is Talking About This Stock. Is It a Good Long-Term Option?
https://www.fool.com/investing/2023/12/02/everyone-is-talking-about-this-stock-is-it-a-good/?source=iedfolrf0000001
Dec 02, 2023 - This company famously helps manage a prevalent chronic illness.
0
An Important History Lesson for Gene-Editing Investors
https://www.fool.com/investing/2023/12/02/an-important-history-lesson-for-gene-editing-inves/?source=iedfolrf0000001
Dec 02, 2023 - Gene editing holds tremendous promise for patients and investors alike. But the road to success won't be easy.
0